Loading...
Images of Masao Sasamata
(0 from 0 )Telephone & Addresses
Masao Sasamata, 58, Lexington, Lincoln St
View Masao's social profiles and photos on Facebook, MySpace, and +40 Networks.
Network Profiles
LinkedIn: Masao Sasamata - Senior Director - Astellas Pharma | LinkedIn
View Masao Sasamata’s profile on LinkedIn, the world's largest professional community. Masao has 1 job listed on their profile. See the complete profile on LinkedIn and discover Masao’s connections and jobs at similar companies.
LinkedIn: Masao Sasamata - Leitender Director - Astellas Pharma | LinkedIn
Sehen Sie sich das Profil von Masao Sasamata auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 1 Job ist im Profil von Masao Sasamata aufgelistet.
LinkedIn: Masao Sasamata - Senior Director - Astellas Pharma | LinkedIn
ユーザー登録をすると、Masao Sasamataさんの詳細なプロフィールやネットワークなどを無料で見ることができます。ダイレクトメッセージで直接やりとりも可能です。
Template Paper
ijbs.org
Toshiyuki Takasu 1, Hirotoshi Kakuta 1, Masao Sasamata 1, Sho-ichi Yamagishi Applied Pharmacology II Pharmacology Research Laboratory, Drug Discovery …
Interests
Masao Sasamata - Patents
www.freshpatents.com
Masao Sasamata patents Recent bibliographic sampling of Masao Sasamata patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Urology - Vol n° 1 - EM consulte
www.em-consulte.com
Le site de référence en informations médicales et paramédicales - EM|consulte
Business Profiles
patentbuddy: Masao Sasamata
ASTELLAS PHARMA INC., Chuo-ku, JP
Property
IN4034/DELNP AGENT FOR TREATING CEREBRAL HEMORRHAGE
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Books & Literature
SCHOLAR - CNKI学术搜索
scholar.cnki.net
CNKI学术搜索是一个基于海量资源的跨学科、跨语种、跨文献类型的学术资源搜索平台，其资源库涵盖各类学术期刊、论文、报纸、专利、标准、年鉴、工具书等，旨在为国内外研究人员提供全面、权威、系统的知识网络。
Official Gazette of the United States Patent and Trademark Office:...
books.google.gr
1A3.4-TETRAHYDROQUINOXALINEDIONE DERIVATIVE Jun-ichi Shishikura; Hiroshi Inami; Shuichi Sakamoto; Shin- ichi Tsukamoto; Masao Sasamata; ...
Related Documents
CiteSeerX — Neuronal nitric oxide synthase activation and...
citeseerx.ist.psu.edu
author = {Mikael J. L. Eliasson and Zhihong Huang and Robert J. Ferrante and Masao Sasamata and Mark E. Molliver and Solomon H. Snyder and Michael A.
Interleukin Enhancer-binding Factor 3/NF110 Is a Target of ...www.scienceopen.com › document
www.scienceopen.com
... Akira Matsuhisa , Naoki Kaneko , Hiroshi Koutoku , Masao Sasamata , Hiroyuki Yokota , Shigeki Kawabata , Kiyoshi Furuichi. Publication date PMC-release: ...
OASIS
www.abstractsonline.com
... Soga 1, Takashi Furutani 1, Satoshi Konagai 1, Hideki Sakagami 1, Mari Nakata 1, Yoko Ueno 1, Hiroshi Fushiki 1, Rika Saito 1, Masao Sasamata 1, Hiroyuki Mano 2, ...
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan,...
www.scienceopen.com
Authors: Toshiyuki Takasu, Hirotoshi Kakuta, Masao Sasamata, Sho-ichi Yamagishi. PMC ID: Journal: International Journal of Biomedical Science : ...
Scientific Publications
Antitumor effects of YM155, a novel survivin suppressant, against...
www.sciencedirect.com
x. Masao Sasamata. Search for articles by this author. Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki , Japan.
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan,...
www.ncbi.nlm.nih.gov
2006 Dec; 2(4): 333–336. PMCID: PMC PMID: · Toshiyuki Takasu,1 Hirotoshi Kakuta,1Masao Sasamata,1 and Sho-ichi Yamagishi2 ...
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan P...:...
www.ingentaconnect.com
Masao Sasamata. 1. , Takafumi Yoshida. 2 and. Sho-ichi Yamagishi. 2,*. 1Applied Pharmacology II Pharmacology Research Labs., Drug Discovery Research, ...
Current Opinion in Pharmacology | Cardiovascular and renal |...
www.sciencedirect.com
Yukinori Arai, Akira Fujimori, Katsumi Sudoh, Masao Sasamata. Pages : Download PDF. Article preview. select article Estrogens and SERMs in ...
Publications
Publications Authored by Masao Sasamata | PubFacts
www.pubfacts.com
Are you Masao Sasamata? Register this Author. Register author Register with ORCID iD
Agonist diversity in 5-HT2C receptor-mediated weight control in rats...
link.springer.com
Food intake and energy expenditure are the two main determinants of body weight. Given that 5-HT2C receptor agonists are reported to have effects on both e
Publications Authored by Sousuke Miyoshi | PubFacts
www.pubfacts.com
Publications Authored by Sousuke Miyoshi
Participation of endogenous endothelin and ETA receptor in...
rd.springer.com
A relationship between endogenous endothelins and bladder overactivity has recently been suggested, but the related endothelin receptor subtype has not bee
Miscellaneous
Masao Sasamata | LinkedIn
www.linkedin.com
View Masao Sasamata’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Masao Sasamata discover inside ...
CA A1 - Agent prophylactique utilise lors de repetition...
patents.google.com
... Masao Sasamata; Current Assignee (The listed assignees may be inaccurate Pharma Inc., Asuka Hayashi, Masanori Suzuki, Masao Sasamata filed Critical ...
EP B1 - 1,2,3,4-tetrahydroquinoxalinedione derivatives and use...
patents.google.com
Other languages: German: English: French; Inventor: Mitsuo Fujii: Hiroshi Inami: Masamichi Okada: Shuichi Sakamoto: Masao Sasamata: Jun-Ichi Shishikura ...
Eye: Sasamata, Masao - Expertscape.com
www.expertscape.com
Masao Sasamata has special expertise in Eye
Hyperlipidemias: Sasamata, Masao - Expertscape.com
expertscape.com
Masao Sasamata has special expertise in Hyperlipidemias
WO A1 - Imidazolylquinoxalinedione derivative and...
patents.google.com
... WO A1, WO A1, WO A1. Inventors, Shuichi Sakamoto, Jun-Ichi Shishikura, Masahiro Iwata, Masamichi Okada, Masao Sasamata.
Masao Sasamata
www.infona.pl
Ipragliflozin is a novel and selective sodium–glucose cotransporter 2 (SGLT2) inhibitor that induces sustained increases in urinary glucose ...
An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan...
www.eurekaselect.com
Author(s): Hirotoshi Kakuta, Katsumi Sudoh, Kazuhiro Terai, Masao Sasamata, Takafumi Yoshida, Sho-ichi Yamagishi. Applied Pharmacology II Pharmacology ...
Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation...
www.jneurosci.org
Mikael J. L. Eliasson, Zhihong Huang, Robert J. Ferrante, Masao Sasamata, Mark E. Molliver, Solomon H. Snyder and Michael A. Moskowitz.
Antidiabetic effects of SGLT2-selective inhibitor ipragliflozin in...
read.qxmd.com
... Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Li Qun, Hiroshi Tomiyama , Yoshinori Kobayashi, Atsushi Noda, Masao Sasamata, Masayuki Shibasaki.
YM155, a Novel Survivin Suppressant, Improves the Antitumor Effect of...
ashpublications.org
... Takahito Nakahara, Aya Kita, Keisuke Mitsuoka, Kentaro Yamanaka, Naoki Kaneko, Sosuke Miyoshi, Masamichi Mori, Hiroshi Koutoku and Masao Sasamata.
Searching in Literature - dkNETdknet.org › ...
dknet.org
Akiyoshi Ohtake | Shuichi Sato | Masao Sasamata | Keiji Miyata. Journal of pharmacological sciences | Overactive bladder (OAB) syndrome is a common ...
The orally active nonpeptide selective endothelin ETA receptor ...
read.qxmd.com
Hironori Yuyama, Akira Fujimori, Masanao Sanagi, Akiko Koakutsu, Katsumi Sudoh, Masao Sasamata, Keiji Miyata. European Journal of Pharmacology
YM155, a selective survivin suppressant, inhibits tumor spread ...www.spandidos-publications.com › ijo
www.spandidos-publications.com
... Hiroshi Koutoku; Masao Sasamata. View Affiliations. Affiliations: Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, ...
Related search requests for Masao Sasamata
| Masamichi Okada Aishi Kimoto Naoki Kaneko | Masahiro Noguchi Toshiyuki Takasu Shuichi Sato | Keiji Miyata Shigeki Kawabata Masamichi Mori |
People Forename "Masao" (832) Name "Sasamata" (1) |
sorted by relevance / date